NUclear MEdicine DIagnostic and Artificial Intelligence

Recruiting now

Conditions studied: Hyperparathyroidism

In brief

Artificial intelligence algorithms for parathyroid adenoma detection in parathyroid scans The aim of the study is to develop programs for the automatic subtraction of planar and tomographic parathyroid images and for the localization of parathyroid adenomas using artificial intelligence tools. Inclusion criteria Patients having undergone a double isotope parathyroid diagnostic examination using the standard Besançon University Hospital protocol (double injection of 123I and 99mTc, pinhole image, low energy high resolution (LEHR) and (single-photon emission tomography / Computed tomography) SPECT/CT +/- (positron emission tomography (PET) Choline). Secondary endpoints Concordance between diagnoses made by nuclear physicians using both methods (current method and new treatment method).

Key facts

Study ID

NCT05963841

Run by

Centre Hospitalier Universitaire de Besancon

People needed

1

Starts

2023-08-01

Expected to finish

2027-08-01

Last updated by the study team

2024-02-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Men and women over 18 years of age who underwent dual-isotope parathyroid scintigraphy.
• No refusal to use data for research purposes
• Retrospective data (after 13/04/2022: Date of posting of patient information in the department) and prospective data

You may not qualify if…

• Patient refusal to use data for research purposes
• Patients who did not benefit from the standard acquisition protocol (123I injection followed by 99mTc 3 hours after LEHR, PINHOLE and SPECT/CT acquisitions)

Where it is running

• CHU Besancon — Besançon, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.